Compare CCEL & COSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CCEL | COSM |
|---|---|---|
| Founded | 1989 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Managed Health Care | Other Pharmaceuticals |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 30.9M | 27.9M |
| IPO Year | 2022 | 2009 |
| Metric | CCEL | COSM |
|---|---|---|
| Price | $4.29 | $0.33 |
| Analyst Decision | Hold | |
| Analyst Count | 1 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 14.2K | ★ 2.5M |
| Earning Date | 04-14-2026 | 04-15-2026 |
| Dividend Yield | ★ 4.26% | N/A |
| EPS Growth | N/A | ★ 46.15 |
| EPS | ★ 0.07 | N/A |
| Revenue | $25,384,279.00 | ★ $65,271,815.00 |
| Revenue This Year | N/A | $54.08 |
| Revenue Next Year | N/A | $32.66 |
| P/E Ratio | $62.86 | ★ N/A |
| Revenue Growth | 9.76 | ★ 19.93 |
| 52 Week Low | $2.72 | $0.16 |
| 52 Week High | $5.01 | $1.32 |
| Indicator | CCEL | COSM |
|---|---|---|
| Relative Strength Index (RSI) | 46.25 | 71.11 |
| Support Level | $3.04 | $0.29 |
| Resistance Level | $4.38 | $0.35 |
| Average True Range (ATR) | 0.27 | 0.03 |
| MACD | -0.03 | 0.01 |
| Stochastic Oscillator | 0.00 | 84.86 |
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.
Cosmos Health Inc is a diversified, vertically integrated healthcare group, owner of proprietary pharmaceutical and nutraceutical brands, generics, manufacturer and distributor of healthcare products, engaged in research & development of medicines and repurposing drugs as well as operator of a telehealth platform. The company has developed its own proprietary branded nutraceutical products, named 'Sky Premium Life' and 'Mediterranation'. Its product portfolio includes generics and over-the-counter pharmaceutical products, medicines, as well as nutraceuticals and biocides. The company's Reportable segments are Wholesale, Pharma manufacturing, and Nutraceutical and pharmaceuticals, with the majority of revenue generated from the Wholesale segment.